Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-09-26
1997-05-06
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 2, 514256, 514269, 514272, 514273, 514274, 514338, 514339, 514255, 514375, 514397, 514398, 514399, 514443, 514469, 514470, A61K 3138, A61K 31415, A61K 3142, A61K 31425
Patent
active
056272006
ABSTRACT:
This invention relates to methods for treating intestinal motility disorders, intestinal ulcerations, including inflammatory bowel disease, ulcerative colitis, Crohn's disease and proctitis, and gastrointestinal ulcerations, depression, prostate disease and dyslipidemia by administering a .beta..sub.3 -adrenoceptor antagonist or agonist.
REFERENCES:
patent: 4309433 (1982-01-01), Smith et al.
patent: 4339333 (1982-07-01), Ainsworth et al.
patent: 4341793 (1982-07-01), Ferris
patent: 4382958 (1983-05-01), Duckworth
patent: 4396627 (1983-08-01), Ainsworth et al.
patent: 4432993 (1984-02-01), Ferris
patent: 4607033 (1986-08-01), Cantello
patent: 4654371 (1987-03-01), Ainsworth et al.
patent: 4886814 (1989-12-01), Reiffen et al.
patent: 5061727 (1991-10-01), Bloom et al.
Giudice et al., Life Science, 44, 19, 1411-1417 (1989).
Simiand et al., Eur. J. of Pharmacol., 219, 193-201 (1992).
Krief et al., J. Clin. Invest., 91, 344-349 (1993).
D.T. Taneja, et al., entitled "Evidence for a Noradrenergic Innervation to `Atypical` Beta Adrenoceptors (or Putative Beta-3 Adrenoceptors) in the Ileum of Guinea Pig". The Journal of Pharmacology and Experimental Therapeutics: 260, 1, 192-200 (1992).
Luciano Manara, et al., entitled "Inhibition of Rat Colonic Motility and Cardiovascular Effects of New Gut-Specific Beta-Adrenergic Phenylethanolaminotetralines", Life Sciences, 44, 1411-1417, (1989).
Peter E. Keane, et al., entitled "Antidepressant Profile in Rodens of SR 58611A, a New Selective Agonist for Atypical .beta.-adrenoceptors", European Journal of Pharmacology, 219, 193-201, (1992).
Laurent J. Emorine, et al., entitled "Tissue Distribution of .beta.3-Adrenergic Receptor mRNA in Man", J. Clin. Invest., 91, 344-349, (1993).
Dow Robert L.
Kreutter David K.
Butterfield Garth C.
Ginsburg Paul H.
Pfizer Inc
Richardson Peter C.
Spivack Phyllis G.
LandOfFree
.beta..sub.3 -Adrenoceptor agonists and antagonists for the trea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta..sub.3 -Adrenoceptor agonists and antagonists for the trea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta..sub.3 -Adrenoceptor agonists and antagonists for the trea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2132947